Harvard Bioscience, Inc.

NASDAQ:HBIO

1.98 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 112.25113.335118.904102.1116.176120.774101.882104.521108.664108.663105.171111.171108.864108.17985.77288.04983.40776.18167.43192.59787.14157.3840.86830.57526.17812.154
Cost of Revenue 46.17952.51651.25244.05951.85457.59354.28556.10659.94159.31957.47558.75358.60456.40244.08945.89343.16138.09434.15646.52343.73128.82420.6415.112.7225.351
Gross Profit 66.07160.81967.65258.04164.32263.18147.59748.41548.72349.34447.69652.41850.2651.77741.68342.15640.24638.08733.27546.07443.4128.55720.22915.47513.4566.803
Gross Profit Ratio 0.5890.5370.5690.5680.5540.5230.4670.4630.4480.4540.4540.4720.4620.4790.4860.4790.4830.50.4930.4980.4980.4980.4950.5060.5140.56
Reseach & Development Expenses 11.76412.32910.7998.68510.71510.9885.6455.3926.424.884.1547.3215.4344.7094.3964.0483.7083.1542.957.1936.2634.1463.1791.5331.1880.325
General & Administrative Expenses 22.7824.49324.30523.50922.7621.38218.57520.9519.83216.82619.93519.718.06317.64315.10926.10425.18124.54620.73731.05526.7818.89214.52000
Selling & Marketing Expenses 24.10825.04124.64219.91623.26424.44321.03620.48620.57718.22517.3319.16917.47316.34511.76310.9710.3529.4998.1116.81715,378.1158,435.1454,840.468000
SG&A 46.88849.53448.94743.42546.02445.82539.61141.43640.40935.05137.26538.86935.53633.98826.87226.10425.18124.54620.73731.05526.7818.89214.5222.7789.8784.039
Other Expenses 5.5256.1225.845.715.746-4.28-0.74-0.179-1.259-1.135-0.051-0.2872.7462.3641.8441.9661.8241.6971.6653.4462.7021.5431.7441.491.2570.027
Operating Expenses 64.17767.98565.58657.8262.48562.19747.69849.5549.64842.50944.00948.94243.71641.06133.11232.11830.71329.39725.35241.69435.74524.5819.44225.80112.3234.391
Operating Income 1.894-7.1661.4-0.5851.4720.984-0.101-2.997-1.7136.6181.5373.1666.07710.2188.0558.4799.5338.697.9244.387.6651.641-4.661-10.3261.1332.412
Operating Income Ratio 0.017-0.0630.012-0.0060.0130.008-0.001-0.029-0.0160.0610.0150.0280.0560.0940.0940.0960.1140.1140.1180.0470.0880.029-0.114-0.3380.0430.198
Total Other Income Expenses Net -4.45-2.246-2.206-7.513-5.879-8.959-1.986-0.081-1.895-2.201-1.102-5.602-1.535-0.6551.757-0.8290.035-0.294-0.7843.253-0.4280.7071.242-38.184-30.416-1.558
Income Before Tax -2.556-9.179-0.14-7.292-5.502-8.515-2.088-3.078-3.6084.4170.4352.2284.5429.5639.8127.659.5688.3967.143.7967.2372.348-3.418-48.51-29.2820.854
Income Before Tax Ratio -0.023-0.081-0.001-0.071-0.047-0.071-0.02-0.029-0.0330.0410.0040.020.0420.0880.1140.0870.1150.110.1060.0410.0830.041-0.084-1.587-1.1190.07
Income Tax Expense 0.8590.3370.1480.518-0.815-3.676-1.2231.22915.4312.062-0.2880.6960.73-9.4522.6732.241.971.7750.8991.4672.9771.6111.791.3590.1370.783
Net Income -3.415-9.516-0.288-7.81-4.687-3.462-0.865-4.307-19.0392.355-1.832.373.81219.0157.2331.673-1.354-2.341-31.8772.3294.260.737-5.208-49.87-29.420.071
Net Income Ratio -0.03-0.084-0.002-0.076-0.04-0.029-0.008-0.041-0.1750.022-0.0170.0210.0350.1760.0840.019-0.016-0.031-0.4730.0250.0490.013-0.127-1.631-1.1240.006
EPS -0.081-0.23-0.007-0.2-0.12-0.097-0.026-0.13-0.570.07-0.060.090.130.660.240.05-0.044-0.077-1.050.080.140.03-0.2-6.23-5.25-0.01
EPS Diluted -0.081-0.23-0.007-0.2-0.12-0.095-0.025-0.13-0.570.07-0.0570.080.130.650.240.05-0.043-0.075-1.040.070.140.03-0.2-6.23-5.25-0.01
EBITDA 8.0330.94411.3115.497.5025.363-0.1011.7991.7269.2857.66811.68211.94913.813.13711.1359.5338.6912.9614.7312.9546.9863.757-8.8362.392.439
EBITDA Ratio 0.072-0.0090.0610.050.0620.0170.0160.0130.0060.0770.0730.0670.0860.1220.1220.1760.1550.1590.1940.1140.1520.1560.2280.9351.2280.201